New diabetes clinical trial: A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone

Published on: August 02, 2023 at 11:00AM
Condition:   Type 2 Diabetes
Interventions:   Drug: Orforglipron;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Not yet recruiting
https://ift.tt/1vFGfgd